| Issue Date | Title | Author(s) |
| May-2011 | Bioactive sphingolipids in response to chemotherapy: A scope on Leukemias | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| Apr-2019 | Cascade therapy with doxorubicin and survivin-targeted tailored nanoparticles: An effective alternative for sensitization of cancer cells to chemotherapy | Dağlıoğlu, Cenk ; Kacı, Fatma Necmiye |
| Jan-2015 | Expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant chronic myeloid leukemia patients and their impact on the clinical progress | Kartal Yandım, Melis |
| 2014 | Expression levels of JAK/STAT signaling genes in newly diagnosed, drug sensitive and resistant chronic myeloid leukemia patients | Kiraz, Yağmur |
| 2013 | Granulocytic sarcoma: a systematic review | Yılmaz, Asu Fergün; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |
| 2011 | The importance of protein profiling in the diagnosis and treatment of hematologic malignancies | Şanlı Mohamed, Gülşah ; Turan, Taylan; Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| 2014 | Prognostic significance of the IgVH mutation status and immunohistochemical analysis of ZAP70 and CD38 in bone marrow biopsies in chronic lymphocytic leukemia | Kahraman Çetin, Nesibe; Kaçar Döger, Füruzan; Kurtgöz, Serkan Erkan; Rusçuklu, Dane; Yavaşoğlu, İrfan |
| Sep-2011 | Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells | Avcı, Çığır Biray; Yılmaz, Sunde; Doğan, Zeynep Özlem; Saydam, Güray; Dodurga, Yavuz; Ekiz, Hüseyin Atakan ; Kartal, Melis; Şahin, Fahri; Baran, Yusuf ; Gündüz, Cumhur |
| Mar-2012 | Role of autophagy in the progression and suppression of leukemias | Ekiz, Hüseyin Atakan ; Can, Geylani; Baran, Yusuf |
| Oct-2010 | Therapeutic applications of bioactive sphingolipids in hematological malignancies | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| 2015 | Therapeutic potentials of fisetin, hesperetin and vitexin on chronic myeloid leukemia and acute myeloid leukemia cells | Adan Gökbulut, Aysun |
